Related Experiment Video

Updated: Aug 11, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Polymyxins: older antibiotics for a new threat

Su Young Lee1, Joseph L Kuti, David P Nicolau

  • 1Center for Anti-Infective Research and Development, Hartford Hospital, USA.

Connecticut Medicine
|February 17, 2006
PubMed

Insights

Polymyxin B and colistin show promise against multidrug-resistant gram-negative infections. Further pharmacodynamic studies are crucial to optimize polymyxin dosing for effectiveness and safety.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Polymyxin B and colistin are effective against multidrug-resistant A. baumannii and P. aeruginosa.
  • These antibiotics are reserved for severe infections due to gram-negative bacilli resistant to other treatments.
  • Potential toxicity necessitates careful consideration of their use.

Purpose of the Study:

  • To highlight the role of polymyxins in treating multidrug-resistant bacterial infections.
  • To emphasize the need for further research into polymyxin pharmacodynamics.
  • To guide the optimization of polymyxin dosage regimens for improved clinical outcomes.

Main Methods:

  • Review of existing literature on polymyxin efficacy and toxicity.
  • Analysis of current recommendations for polymyxin use.
  • Identification of knowledge gaps in polymyxin pharmacodynamics.

Main Results:

  • Polymyxins provide a vital treatment option for specific multidrug-resistant gram-negative infections.
  • Current usage guidelines emphasize restricted application due to toxicity concerns.
  • Pharmacodynamic data are insufficient to establish optimal dosing strategies.

Conclusions:

  • Polymyxins remain important agents for treating highly resistant gram-negative infections.
  • Further pharmacodynamic studies are essential to refine dosing and minimize toxicity.
  • Optimized dosing regimens will enhance the clinical utility of polymyxins.

More Related Videos

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...